MS drugs produced in Iran as effective as foreign ones
TEHRAN – All the required drugs for treating multiple sclerosis (MS) are produced domestically and their effectiveness is equal to those of foreign ones, prominent neurologist Masud Nabavi said recently. Touching on the spectacular development of Iran in manufacturing MS drugs, Nabavi said these domestically produced drugs can compete with foreign drugs. Over the past two years, many MS drugs were granted license by the United States’ Food and Drug Administration (FDA) and European Medicines Agency (EMA), he said, adding that Iran has also ...
Click
To Read Full Article
